Concentration of evobrutinib, a BTK inhibitor, in cerebrospinal fluid during treatment of patients with relapsing multiple sclerosis in a phase 2 study

Karolina Piasecka‐Stryczynska, Konrad Rejdak, Martin C. Dyroff, Yann Hyvert, Kristina Holmberg, Matthew Mandel, Carolina Maria Pires Cunha, David Mitchell, Emily C. Martin, Xavier Montalbán